Defined Daily Doses: An instrument for cost control in Health Care System?;Defined Daily Doses: Ein instrument zur kostensteuerung im Gesundheitswesen?

Gesundheitsokonomie und Qualitatsmanagement

Volumn 13, Issue 1, 2008, Pages 38-42

  Wasem, Jürgen ^a,c   Bramlage, P ^b  

^a FB 5 Wirtschaftswissenschaften

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Cost benefit ratio; DDD; Equivalent dose; Hypertension

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPROSARTAN; IRBESARTAN; LOSARTAN; OLMESARTAN; TELMISARTAN; THIAZIDE DIURETIC AGENT; VALSARTAN;

BLOOD PRESSURE; CARDIOVASCULAR RISK; COST BENEFIT ANALYSIS; COST CONTROL; DRUG COST; GERMANY; HEALTH CARE SYSTEM; HYPERTENSION; REVIEW;

EID: 40149096706     PISSN: 14322625     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-963546     Document Type: Review

References (29)